Ontology highlight
ABSTRACT:
SUBMITTER: Scherer LD
PROVIDER: S-EPMC6411696 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Scherer Lauren D LD Brenner Malcolm K MK Mamonkin Maksim M
Frontiers in oncology 20190305
Development of chimeric antigen receptor (CAR)-modified T cells for the treatment of T-lineage leukemia and lymphoma has encountered several unique challenges. The most widely expressed tumor antigen targets for malignant T cells are often also expressed on non-malignant T cells. Transducing T cells with CARs targeted to these shared antigens can therefore promote over-activation or fratricide of CAR T cells, reducing their therapeutic potency. If fratricide is resolved, clinical CAR T cell acti ...[more]